Out and up

Industrial synthetic biology company Amyris Inc. (NASDAQ:AMRS) may not have hit the numbers it hoped for in its IPO last week, but it didn't disappoint in the after-market, either.

On Tuesday, the company raised $84.8 million through the sale of 5.3 million shares at $16 in the new issue. The deal came in below the proposed range of $18-$20 and valued the company at $687.7 million. A $19 price would have raised $100.7 million and valued the company at $816.7 million...